Gujarat Terce Laboratories (BOM:524314) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories 3-Year EBITDA Growth Rate?

Gujarat Terce Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was ₹1.25.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Gujarat Terce Laboratories was 34.50% per year. The lowest was -32.10% per year. And the median was -2.40% per year.

Competitive Comparison of Gujarat Terce Laboratories's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Terce Laboratories's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gujarat Terce Laboratories's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Terce Laboratories's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Gujarat Terce Laboratories's 3-Year EBITDA Growth Rate falls into.

Gujarat Terce Laboratories 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Gujarat Terce Laboratories (BOM:524314) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Gujarat Terce Laboratories 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Gujarat Terce Laboratories's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Gujarat Terce Laboratories (BOM:524314) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015

Website

https://www.gujaratterce.in

Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines